Who is hesitant about Covid-19 vaccines? The profiling of participants in a French online cohort.
Cohort
Cohorte
Covid-19
Hésitation vaccinale
Profil
Profiling
Vaccine hesitancy
Journal
Revue d'epidemiologie et de sante publique
ISSN: 0398-7620
Titre abrégé: Rev Epidemiol Sante Publique
Pays: France
ID NLM: 7608039
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
16
06
2021
revised:
21
01
2022
accepted:
25
02
2022
pubmed:
17
4
2022
medline:
25
5
2022
entrez:
16
4
2022
Statut:
ppublish
Résumé
To report the characteristics of vaccine-hesitant individuals in a French-speaking adult population in the context of the SARS-CoV-2 pandemic; and to identify predictors of hesitancy about Covid-19-related vaccines. Between April and May 2020, 1640 French-speaking adults participating in an online cohort were classified according to their attitudes towards vaccination as: "hesitant", "anti-vaccination", and "pro-vaccination". Descriptive statistics, univariate multinomial regression models and multivariate analyses were compiled and carried out. At the time of inclusion, compared to pro-vaccination participants, hesitant participants were more frequently females (p=0.044), not annually vaccinated against flu (p=0.026), less optimistic about the discovery of a treatment against Covid-19 in a few months (p<0.001), less ready to undergo this treatment (p<0.001), presenting less trust in the ability of public health authorities to control the pandemic (p=0.036) and reporting lower scores on knowledge-related scales (p values from <0.001 to 0.002). Univariate analyses confirmed these results with odds ratios ranging from 1.51 [1.05-2.17] to 2.19 [1.56-3.07]. In the multivariate models, the remaining variables associated with hesitant compared to pro-vaccination attitudes were discovery of a treatment against Covid-19 in a few months (OR=2.57 [1.73-3.81]), being ready to undergo this treatment (OR=7.07 [4.89-10.22]), digital vaccine literacy (OR=1.70 [1.14-2.54]) and general health literacy (OR=1.49 [1.03-2.15]). In a continuum of relative acceptance of Covid-19-related vaccines, hesitant individuals were situated in between the behaviours and characteristics of pro-vaccination and anti-vaccination groups. While their characteristics were in line with the literature, this study was the first to report data on health literacy, digital vaccine literacy and capacity to detect fake news associated with vaccine hesitancy. While failing to identify straightforward predictors, findings suggest that continued education and communication campaigns focused on improving vaccine literacy, particularly among women younger than 35 years, could heighten the proportion of persons accepting vaccination.
Identifiants
pubmed: 35428543
pii: S0398-7620(22)00292-9
doi: 10.1016/j.respe.2022.02.004
pmc: PMC8958178
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
123-131Informations de copyright
Copyright © 2022 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interest statement We wish to confirm that there are no known conflicts of interest associated with this publication and that there has been no significant financial support for this work that could have influenced its outcome.
Références
Eur J Public Health. 2018 Oct 1;28(5):934-939
pubmed: 29982349
J Public Health (Oxf). 2021 Dec 10;43(4):695-702
pubmed: 33693905
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
Vaccine. 2020 Oct 21;38(45):7002-7006
pubmed: 32988688
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Soc Sci Med. 2012 Jun;74(11):1712-20
pubmed: 22361090
Hum Vaccin Immunother. 2019;15(11):2527-2533
pubmed: 31050594
EBioMedicine. 2016 Oct;12:295-301
pubmed: 27658738
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
Hum Vaccin Immunother. 2013 Aug;9(8):1755-62
pubmed: 23744504
Lancet Infect Dis. 2020 Jul;20(7):769-770
pubmed: 32445713
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Rev Epidemiol Sante Publique. 2009 Oct;57(5):361-72
pubmed: 19674855
Ann Intern Med. 2020 Dec 15;173(12):964-973
pubmed: 32886525
Med Decis Making. 2015 Nov;35(8):948-58
pubmed: 26338176
Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080
pubmed: 32991230
Nat Immunol. 2019 Oct;20(10):1257-1259
pubmed: 31477920
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Int J Nurs Stud. 2021 Feb;114:103854
pubmed: 33326864
Psychol Med. 2020 Oct 19;:1-3
pubmed: 33070804
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
CMAJ. 2017 Jan 23;189(3):E124-E125
pubmed: 28246159
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
J Health Psychol. 2022 Sep;27(10):2402-2419
pubmed: 34474616
Z Gesundh Wiss. 2022 Jan 07;:1-25
pubmed: 35018277
BMC Public Health. 2013 Jul 16;13:658
pubmed: 23855504
Hum Vaccin Immunother. 2014;10(9):2584-96
pubmed: 25483505
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Vaccine. 2012 May 28;30(25):3778-89
pubmed: 22172504
Public Health Rep. 2011 Jul-Aug;126 Suppl 2:135-46
pubmed: 21812176
SAGE Open Med. 2018 Sep 21;6:2050312118801250
pubmed: 30319778
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204